Monophosphoryl Lipid A (MPL) Formulations for the Next Generation of Vaccines
- 1 September 1999
- Vol. 19 (1) , 103-107
- https://doi.org/10.1006/meth.1999.0834
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Development of adjuvant-active nonionic block copolymersAdvanced Drug Delivery Reviews, 1998
- A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalariaNew England Journal of Medicine, 1997
- Cytokines and their effects on maturation, differentiation and migration of dendritic cellsArchives of Dermatological Research, 1996
- Effects of Tumor Necrosis Factor and Dexamethasone on the Regulation of Interferon-?? Induction by Monophosphoryl Lipid AJournal of Immunotherapy, 1994
- Structural Requirements of Lipid a for Endotoxicity and Other Biological ActivitiesCRC Critical Reviews in Microbiology, 1989
- Synthetic and natural Escherichia coli free lipid A express identical endotoxic activitiesEuropean Journal of Biochemistry, 1985
- A new immunomodulator with potential clinical applications: Monophosphoryl lipid A, a detoxified endotoxinClinical Immunology Newsletter, 1985
- Peptides as requirement for immunotherapy of the guinea-pig line-10 tumor with endotoxinsCancer Immunology, Immunotherapy, 1979
- Biologically active components from mycobacterial cell walls: IV. protection of mice against aerosol infection with virulent Mycobacterium tuberculosisCellular Immunology, 1975
- STUDIES ON THE O ANTIGEN OF SALMONELLA TYPHOSAThe Journal of Experimental Medicine, 1956